Effect of cholecalciferol recommended daily allowances on vitamin d status and fabroblast growth factor- 23, in Acute burn patients
Keywords:
supplements containing, intriguing, cholecalciferolAbstract
People who have had burns may get vitamin D insufficiency. Vitamin D intakes are not recommended in the dietary guidelines for burn victims, and the majority of studies solely include ergocalciferol as a source of vitamin D. (VD2). Providing children with burns with nutritional support. The objectives of this study were to: (1) describe the VD status of adult burns; (2) examine the impact of (VD3) supplementation on VD metabolism during acute burn treatment; and (3) look into the relationship between FGF23 and (CRP). Epidemiology study was created. Methods: Adults (18 years and older) who were hospitalized within 24 hours of a burn incident and had a burn surface area participated between March 2012 and January 2013. (BSA). Along with VD3 (400-600 IU) either orally or intravenously each day, patients also received a multivitamin complex (200–220 IU). After admission (Day 0), calcium, phosphate, albumin, and CRP levels were checked once a week for four weeks. Third-generation (PTH), 25(OH)-D, and 1-25(OH)2-D blood concentrations, as well as (FGF23) and PTH, were also measured. You may get the data as a ratio or as the midpoint value (min–max).
Downloads
References
Auron, A., & Alon, U. S. (2018). Hypercalcemia: a consultant’s approach. Pediatric Nephrology, 33(9), 1475-1488.
Berger, M. R. (1982). Painful tendon problems of the hand: trigger thumb, trigger finger and de Quervain's syndrome. Orthopaedic Nursing, 1(5), 20-23.
Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713–6.
Galesanu, C., & Mocanu, V. (2015). Vitamin D deficiency and the clinical consequences. The Medical-Surgical Journal, 119(2), 310-318.
Gottschlich MM, Mayes T, Khoury J, Warden GD. Hypovitaminosis D in acutely injured pediatric burn patients. J Am Dent Assoc 2004;104:931–41. [quiz 1031].
Gottschlich, M. M., Mayes, T., Khoury, J., & Kagan, R. J. (2017). Clinical trial of vitamin D2 vs D3 supplementation in critically ill pediatric burn patients. Journal of Parenteral and Enteral Nutrition, 41(3), 412-421.
Haussler, M. R., Haussler, C. A., Whitfield, G. K., Hsieh, J. C., Thompson, P. D., Barthel, T. K., ... & Jurutka, P. W. (2010). The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging. The Journal of steroid biochemistry and molecular biology, 121(1-2), 88-97.
Herndon, D. N., & Tompkins, R. G. (2004). Support of the metabolic response to burn injury. The Lancet, 363(9424), 1895-1902.
Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266–81.
Holick, M. F. (2002). Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Current Opinion in Endocrinology, Diabetes and Obesity, 9(1), 87-98.
Huybers, S., Naber, T. H., Bindels, R. J., & Hoenderop, J. G. (2007). Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6. American Journal of Physiology-Gastrointestinal and Liver Physiology.
Jones, G. (2007, July). Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1a-hydroxylase in the classical and nonclassical actions of 1a, 25-dihydroxyvitamin D3. In Seminars in dialysis (Vol. 20, No. 4, p. 316). Blackwell Publishing Ltd.
Klein GL, Herndon DN, Chen TC, Kulp G, Holick MF. Standard multivitamin supplementation does not improve vitamin D insufficiency after burns. J Bone Miner Metab 2009;27:502–6.
Klein GL. Should we give vitamin D to severe burns patients? The conundrum. Burns 2013
Klein, G. L. (2006). Burn-induced bone loss: importance, mechanisms, and management. Journal of Burns and Wounds, 5.
Kovesdy CP, Quarles LD. Fibroblast growth factor-23: what we know, what we don’t know, and what we need to know. Nephrol Dial Transplant 2013;28:2228–36.
Leiu, K. H., Chin, Y. S., Mohd Shariff, Z., Arumugam, M., & Chan, Y. M. (2020). High body fat percentage and low consumption of dairy products were associated with vitamin D inadequacy among older women in Malaysia. PLoS One, 15(2), e0228803.
Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007;18:1637–47.
Mehta S, Booth S, Dheansa B. Should we give vitamin D to severe burns patients? Burns 2013;39:830–1.
Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, et al. Fibroblast growth factor 23 and inflammation in CKD. Clin J Am Soc Nephrol 2012;7:1155–62.
Papaioannou, A., Kennedy, C. C., Giangregorio, L., Ioannidis, G., Pritchard, J., Hanley, D. A., ... & Adachi, J. D. (2011). A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC musculoskeletal disorders, 12(1), 1-10.
Peng, X., Yan, H., You, Z., Wang, P., & Wang, S. (2005). Clinical and protein metabolic efficacy of glutamine granules-supplemented enteral nutrition in severely burned patients. Burns, 31(3), 342-346.
Pham, T. N., Cancio, L. C., & Gibran, N. S. (2008). American Burn Association practice guidelines burn shock resuscitation. Journal of burn care & research, 29(1), 257-266.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–8.
Rousseau, A. F., Damas, P., Ledoux, D., & Cavalier, E. (2014). Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients. Burns, 40(5), 865-870.
Wesseling-Perry K, Juppner H. The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications. Bone 2013;54:222–9.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.